Connect Biopharma Limite... (CNTB)
NASDAQ: CNTB
· Real-Time Price · USD
1.63
-0.18 (-9.94%)
At close: Aug 20, 2025, 10:05 AM
Connect Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Net Income | -12.9M | -23.22M | 7.65M | -28.8M | -30.58M | -56.68M | -61.92M | -56.65M | -145.71M |
Depreciation & Amortization | 171K | 184K | 476K | 481.87K | 506.13K | 527.3K | 502.72K | 412.05K | 221.39K |
Stock-Based Compensation | 951K | 4.89M | 1.84M | 3.26M | 1.11K | 1.43K | 2.08K | 2.9K | 1.5K |
Other Working Capital | -2.01M | -82.08K | n/a | 13.99M | -1.27M | 876.45K | 2.47M | -2.33M | -724.62K |
Other Non-Cash Items | -288K | 126.13K | -18.9M | 8.67M | 2.16M | 10.74M | 856.07K | 691.6K | 108.04M |
Deferred Income Tax | n/a | n/a | n/a | 1.46M | -1.46M | -505.24K | 2.12M | n/a | n/a |
Change in Working Capital | -526K | 2.44M | 960K | 11.2M | -1.72M | 1.43M | 5.59M | 4.19M | -954.98K |
Operating Cash Flow | -12.59M | -15.58M | -7.38M | -16.84M | -31.09M | -44.49M | -52.85M | -45.66M | -39.08M |
Capital Expenditures | -303K | -312.08K | -436K | -8.33K | -285.67K | -2.46M | -1.74M | -315.65K | -7.07M |
Cash Acquisitions | n/a | -2.94M | n/a | 2.96M | -16.5K | 6.12K | 35.82K | n/a | n/a |
Purchase of Investments | -7.91M | -15.41M | n/a | -1.64M | -30.96M | -30.94M | -80.55M | -11.23M | -6.57M |
Sales Maturities Of Investments | 13.34M | -39.7K | n/a | 39.69M | 65.5M | 27.39M | 6.48M | 11.29M | 8.61M |
Other Investing Acitivies | n/a | 2.26M | 13.15M | -100.5K | 16.5K | -6.12K | -35.82K | 56.49 | -702.95 |
Investing Cash Flow | 5.13M | -15.72M | 3.03M | 40.9M | 34.25M | -6M | -75.81M | -257.55K | -5.03M |
Debt Repayment | n/a | 290K | n/a | -290K | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.46K | -194.59 |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 161K | -142K | -46K | -118.65K | -61K | -59.03K | 35.18K | -6.18M | -17.3M |
Financial Cash Flow | 161K | 272.42K | -46K | -115.72K | -130.28K | -124.69K | 35.18K | 979.46K | 203.66M |
Net Cash Flow | -7.08M | -31.94M | -3.93M | -81.61M | 2.02M | -62.57M | -126.09M | -45.59M | 159.55M |
Free Cash Flow | -12.89M | -15.89M | -8.41M | -16.85M | -31.37M | -46.94M | -54.59M | -45.97M | -46.15M |